Regeneron Pharmaceuticals Stock Forecast

Buy or Hold candidate since Jul 28, 2026 Gain 9.70%

The Regeneron Pharmaceuticals stock price gained 3.29% on the last trading day (Friday, 31st Jul 2026), rising from $738.34 to $762.63. It has now gained 7 days in a row. It is not often that stocks manage to gain so many days in a row, and falls for a day or two should be expected. During the last trading day the stock fluctuated 5.52% from a day low at $724.79 to a day high of $764.82. The price has risen in 8 of the last 10 days and is up by 12.7% over the past 2 weeks. Volume fell on the last day by -303 thousand shares and in total, 1 million shares were bought and sold for approximately $859.16 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

Given the current horizontal trend, you can expect Regeneron Pharmaceuticals stock with a 90% probability to be traded between $603.60 and $764.62 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

REGN Signals & Forecast

Mostly positive signals in the chart today. The Regeneron Pharmaceuticals stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $695.24 and $652.53. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday, June 01, 2026, and so far it has risen 26.97%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for Regeneron Pharmaceuticals stock

On the downside, the stock finds support just below today's level from accumulated volume at $629.68 and $627.74. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Regeneron Pharmaceuticals finds support just below today's level at $629.68. If this is broken, then the next support from accumulated volume will be at $627.74 and $609.94.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $40.03 between high and low, or 5.52%. For the last week, the stock has had daily average volatility of 3.90%.

The Regeneron Pharmaceuticals stock is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some stocks may go long and hard while being overbought and the RSI is still moving upwards. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely, and it is of great importance that the stock manages to break the trend before that occurs. Since the Regeneron Pharmaceuticals has been rising for 7 days in a row, the risk over the next couple of days has increased. We don't expect a major reaction as the stock is in very good shape technically, and therefore hold a positive evaluation despite the very short term risk.

Our recommended stop-loss: $740.21 (-2.94%) (This stock has medium daily movements and this gives medium risk. The RSI14 is 78 and this increases the risk substantially. There is a buy signal from a pivot bottom found 42 days ago.)

Trading Expectations (REGN) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect Regeneron Pharmaceuticals to open at $750.75, and during the day (based on 14 day Average True Range), to move between $752.21 and $773.05, which gives a possible trading interval of +/-$20.83 (+/-2.77%) up or down from last closing price. If Regeneron Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 2.77% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $629.68, some $132.95 (17.43%) from the current price of $762.63, our system finds the risk reward attractive.

Is Regeneron Pharmaceuticals stock A Buy?

Regeneron Pharmaceuticals holds several positive signals and is considered to be a good choice at current levels. We expect the Regeneron Pharmaceuticals stock to perform great in the short-term period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Strong Buy candidate.

Current score: 5.331 Strong Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $750.75 ( 1.56%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk